Results 141 to 150 of about 1,197,586 (303)

THE CARRIER

American Journal of Public Health, 1923
openaire   +3 more sources

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

The demon and the darling of the gods; a drama, by Wilbur Carrier ...

, 1914
3 p.
Carrier, J. Wilbur.
core  

High out-of-plane piezoelectric response in Janus SeWZH (Z = N, P, As) semiconductors: a first-principles prediction. [PDF]

RSC Adv
Kartamyshev AI, Nha VQ, Hieu LD, Vu TV, Truong PT, Phuc HV, Hiep NT.   +6 more
europepmc   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

Molecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober, Leire Moreno‐Cugnon, Laura Martínez‐Pérez, Amaia Ercilla, Amaia Zabala‐Letona, Adrián Vicente‐Barrueco, Maider Fagoaga‐Eugui, Saioa Garcia‐Longarte, Blanca Calle‐Ciborro, Encarnación Pérez‐Andrés, Onintza Carlevaris, Sara Pozo, Isabel Mendizabal, Ugo Mayor, Arkaitz Carracedo, Violaine Sée, Edurne Berra   +16 more
wiley   +1 more source

TYPHOID CARRIERS [PDF]

American Journal of Public Health, 1926
openaire   +5 more sources

Photon cascade engineering in AgCdF₃/Cu₂GeSiS₄ dual-absorber solar cells: from spectral complementarity to device excellence. [PDF]

RSC Adv
Hossain MF, Himel HA, Al-Humaidi JY, Badi N, Al-Atawi FH, Irfan A, Rahman MF.   +6 more
europepmc   +1 more source

Carriers of Tuberculosis [PDF]

BMJ, 1941
openaire   +2 more sources

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

Molecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder, Klaas de Lint, Hồ Mỹ Phúc Võ, Mariana M. Góis, Rosalie A. Kampen, Marta San Martin Alonso, Ilse Nootenboom, Veronica Garzero, Tiemen J. Wendel, Rob M. F. Wolthuis, Sylvie M. Noordermeer   +10 more
wiley   +1 more source

NbN Broadband Plasmonic Absorbers for Efficient Hot-Carrier Injection Toward Improved Solar-to-Hydrogen Conversion. [PDF]

Adv Sci (Weinh)
Peng TY, Huang TF, Yamaguchi T, Chen JW, Kuo HY, Zhuang YR, Shiu HW, Im S, Zhao Y, Tanaka T, Chou HH, Lu YJ.   +11 more
europepmc   +1 more source